We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
AI created mini-proteins for precise activation of GPCR in vivo. Superior to antibodies, fewer side effects. Market and impact analysis. Read more.
